Login to Your Account



Guilford Begins Phase III Program For Aquavan Injection In Sedation

By Kim Coghill


Tuesday, May 11, 2004
Guilford Pharmaceuticals Inc. on Monday said it initiated a Phase III development program for Aquavan Injection, a candidate for procedural sedation. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription